Monday, December 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Lumen Technologies Launches Consent Solicitation to Finalize Transactions

Elaine Mendonca by Elaine Mendonca
March 11, 2024
in Breaking News
0
The Rise of Enterprise Business Intelligence Platforms: Transforming Operations in the Healthcare Sector
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Lumen Technologies, Inc. has recently launched a consent solicitation to make changes to specific indentures and finalize transactions as per a transaction support agreement. This initiative began on March 8, 2024, to streamline the completion of transactions specified in the revised transaction support agreement. Lumen is actively encouraging lenders with existing term loans to participate in transactions associated with the credit agreements. The company aims to wrap up the TSA transactions by the end of March, subject to meeting all remaining closing requirements.

LUMN Stock Performance Analysis on March 11, 2024: Trading in Middle of 52-Week Range

On March 11, 2024, LUMN stock showed a mixed performance as it traded in the middle of its 52-week range and above its 200-day simple moving average. The stock opened at $1.82, which was $0.00 lower than its previous close. Throughout the trading day, the price of LUMN shares decreased by $0.01, representing a 0.27% drop.

LUMN Stock Performance Analysis: Revenue, Net Income, and EPS Decline in 2024

On March 11, 2024, LUMN stock performance was closely analyzed based on the financial data provided by CNN Money. The telecommunications company reported a total revenue of $14.56 billion for the past year, which decreased by 16.71% compared to the previous year. However, the total revenue remained flat at $3.52 billion for the last quarter.

In terms of net income, LUMN reported a significant loss of $10.30 billion for the past year, which represents a decrease of 565.25% compared to the previous year. On the other hand, the net income for the last quarter showed some improvement, with a loss of $2.00 billion, which remained unchanged from the previous quarter.

Earnings per share (EPS) also took a hit, with a reported EPS of -$10.48 for the past year, representing a decrease of 581.76% compared to the previous year. The EPS for the last quarter was reported at -$2.03, which decreased by 2457.25% compared to the previous quarter.

Overall, LUMN stock performance on March 11, 2024, reflected a challenging year for the company, with significant decreases in total revenue, net income, and EPS. Investors and analysts will be closely monitoring the company’s financial health and strategic decisions to navigate through these challenging times and drive future growth.

Tags: LUMN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Aerospace and Defense Market Capitalization

BOS Intelligent Robotics Division Secures 615000 Order from Israeli Defense Client

Finance_Financing

The Importance of Circuit Breakers in Stock Trading

Food Retailers Market Capitalization

PVH Corps Short Interest Sees Significant Drop

Recommended

Ocugen Stock

Ocugen’s Financial Race Against Time

1 month ago
Citizens Stock

Citizens Financial Group: A Study in Market Contradictions

4 months ago
Asbury Automotive Stock

Mixed Signals Emerge as Asbury Automotive Posts Record Earnings

3 months ago
Intellia Therapeutics Stock

Intellia Therapeutics Emerges as Gene Editing Front-Runner with Accelerated Trial Progress

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Bitcoin Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

IonQ Secures Major European Contract Extension Valued at Over $60 Million

Lynas Gains Market Favor with Key Index Inclusion Amid Operational Hurdles

Adobe’s Strategic Countermove in the AI Video Arena

Alphabet’s AI Strategy Gains Momentum with New Model and Major Deals

Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push

Wolfspeed Secures Financial and Strategic Milestones

Trending

Hims & Hers Stock
Healthcare

Hims & Hers Charts North American Growth with Canadian Market Entry

by Robert Sasse
December 22, 2025
0

The telehealth provider Hims & Hers Health is accelerating its international strategy with a decisive move into...

ServiceNow Stock

ServiceNow Shares Navigate Post-Split Turbulence Amid Acquisition Talks

December 22, 2025
Pfizer Stock

Pfizer Shares Face a Multifaceted Squeeze

December 22, 2025
IonQ Stock

IonQ Secures Major European Contract Extension Valued at Over $60 Million

December 22, 2025
Lynas Stock

Lynas Gains Market Favor with Key Index Inclusion Amid Operational Hurdles

December 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Hims & Hers Charts North American Growth with Canadian Market Entry
  • ServiceNow Shares Navigate Post-Split Turbulence Amid Acquisition Talks
  • Pfizer Shares Face a Multifaceted Squeeze

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com